Trial · NCT02513667
Adverse events192
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 192
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal Pain | Gastrointestinal disorders | ALK-inhibitor Naive Patients | 4 | 8 | |
| other | Abdominal Pain | Gastrointestinal disorders | Patients Recieved Prior ALK Inhibitor | 3 | 5 | |
| other | Acid Reflux | Gastrointestinal disorders | ALK-inhibitor Naive Patients | 1 | 8 | 1 |
| other | Acid Reflux | Gastrointestinal disorders | Patients Recieved Prior ALK Inhibitor | 0 | 5 | 0 |
| other | Alkaline phosphatase increased | Investigations | ALK-inhibitor Naive Patients | 3 | 8 | 6 |
| other | Alkaline phosphatase increased | Investigations | Patients Recieved Prior ALK Inhibitor | 3 | 5 | 5 |
| other | Increased ALT | Investigations | ALK-inhibitor Naive Patients | 4 | 8 | 7 |
| other | Increased ALT | Investigations | Patients Recieved Prior ALK Inhibitor | 2 | 5 | 6 |
| other | Anemia | Blood and lymphatic system disorders | ALK-inhibitor Naive Patients | 0 | 8 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Patients Recieved Prior ALK Inhibitor | 1 | 5 | 1 |
| other | Appetite Change (dysgeusia, anorexia, decreased appetite) | Metabolism and nutrition disorders | ALK-inhibitor Naive Patients | 2 | 8 | 3 |
| other | Appetite Change (dysgeusia, anorexia, decreased appetite) | Metabolism and nutrition disorders | Patients Recieved Prior ALK Inhibitor | 1 | 5 | 1 |
| other | Anxiety | Psychiatric disorders | ALK-inhibitor Naive Patients | 0 | 8 | 0 |
| other | Anxiety | Psychiatric disorders | Patients Recieved Prior ALK Inhibitor | 1 | 5 | 1 |
| other | Increased AST | Investigations | ALK-inhibitor Naive Patients | 3 | 8 | 6 |
| other | Increased AST | Investigations | Patients Recieved Prior ALK Inhibitor | 3 | 5 | 3 |
| other | Pain - Back | Injury, poisoning and procedural complications | ALK-inhibitor Naive Patients | 1 | 8 | 1 |
| other | Pain - Back | Injury, poisoning and procedural complications | Patients Recieved Prior ALK Inhibitor | 3 | 5 | 4 |
| other | Benign Familial Tremmors | Congenital, familial and genetic disorders | ALK-inhibitor Naive Patients | 1 | 8 | 1 |
| other | Benign Familial Tremmors | Congenital, familial and genetic disorders | Patients Recieved Prior ALK Inhibitor | 0 | 5 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02513667/events